Federal regulators have agreed to review a Swiss pharmaceutical company's applications for two cheaper generic versions of ...
On June 16, 2026, the Centers for Medicare & Medicaid Services (CMS) published a proposed rule that would codify the Medicare Drug Price ...
When life sciences startups think about patent strategy, the natural instinct is to focus on the core science — the novel compound, the ...
Health advocacy groups have urged the government to reject TRIPS-plus provisions in Thailand's free trade negotiations with the European Union (EU), warning they could delay access to generic ...
On July 6th, Sen. Jim Banks (R-Ind.) sent a letter to Commerce Secretary Howard Lutnick urging the U.S. Patent and Trademark ...
Healthcare veteran Dr Douglas Williams discusses the impact of recent political upheaval in the US and the prospect of major ...
Biopharmaceutical developers should introduce risk-based, phase-appropriate characterization strategies for quality control ...
In corporate management, nothing is more daunting than uncertainty, not even loss itself. If the scale of a loss can be predicted, countermeasures can ...
AVE has made a breakthrough with a phase III insomnia trial for its soft gel cannabidiol to manage sleeplessness. ... Read ...
PharmAla Biotech Holdings Inc. (CSE: MDMA)(OTCQB: MDXXF) , a biotechnology company focused on the research, development, and manufacturing of LaNeo™ MDMA and novel derivatives of MDMA (MDXX class ...
Industry groups are asking the US Food and Drug Administration (FDA) for greater transparency into its Commissioner's National Priority Voucher (CNPV) pilot, including how the agency intends to ...
TEMPO.CO, Jakarta - The Ministry of Health will bring in doctors from Belarus to train medical personnel in Indonesia. Both ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results